Why the study?
Does low-dose captopril reduce blood pressure in men with uncomplicated mild to moderate hypertension?
Does low-dose captopril reduce blood pressure in men with uncomplicated mild to moderate hypertension?
Low-dose captopril (37.5 mg/day) is as effective as higher doses for treating uncomplicated hypertension, and its antihypertensive effect is greatly enhanced by the addition of hydrochlorothiazide.
Answers are grounded in this paper and cite their sources.
Supports low-dose captopril initiation in mild-moderate hypertension; confirms equivalent efficacy to higher doses with additive diuretic benefit.
• We randomized 495 men with uncomplicated hypertension (diastolic BP, 92 to 109 mm Hg) to one of five captopril regimens at the following dosages: 12.5 mg three times a day, 25 mg three times a day, 37.5 mg twice daily, 50 mg three times a day, or placebo three times a day. After seven weeks, BP reduction with each captopril dose was greater than in the placebo group, averaging 10.2 to 14.2/8.6 to 10.5 mm Hg. Captopril, 37.5 mg/day, was as effective as 150 mg/day. Hydrochlorothiazide, 25 mg twice daily, was added for seven more weeks to all patients receiving placebo and to two thirds of those randomized to captopril therapy. Blood pressure reduction averaged 12.0/8.7 mm Hg in those receiving hydrochlorothiazide alone and 24.9 to 26.4/14.4 to 17.3 mm Hg in those receiving a combination of hydrochlorothiazide and captopril. Added hydrochlorothiazide greatly enhanced the antihypertensive response. The 15 terminations (4.3%) related to captopril were not life threatening. Conclusion: Captopril treatment of uncomplicated hypertension may be initiated with 37.5 mg/day—half the currently recommended dose. (Arch Intern Med1984;144:1947-1953)
No takes yet. Share an insight, caveat, or question.
A 1984 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: